nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d
|
Davidson, Michael H. |
|
2003 |
25 |
11 |
p. 2738-2753 16 p. |
artikel |
2 |
A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction
|
Govier, Fred |
|
2003 |
25 |
11 |
p. 2709-2723 15 p. |
artikel |
3 |
A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus
|
Korytkowski, Mary |
|
2003 |
25 |
11 |
p. 2836-2848 13 p. |
artikel |
4 |
A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia
|
Schwartzberg, Lee |
|
2003 |
25 |
11 |
p. 2781-2796 16 p. |
artikel |
5 |
A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: The Val-Syst study
|
Malacco, Ettore |
|
2003 |
25 |
11 |
p. 2765-2780 16 p. |
artikel |
6 |
A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization
|
Valuck, Robert J. |
|
2003 |
25 |
11 |
p. 2936-2957 22 p. |
artikel |
7 |
Bioequivalence and other unresolved issues in generic drug substitution
|
Meredith, Peter |
|
2003 |
25 |
11 |
p. 2875-2890 16 p. |
artikel |
8 |
Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia
|
Berger, Ariel |
|
2003 |
25 |
11 |
p. 2809-2821 13 p. |
artikel |
9 |
Common sense isn't always (common)
|
Walson, Philip D. |
|
2003 |
25 |
11 |
p. 2897- 1 p. |
artikel |
10 |
Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine
|
Williams, Paul |
|
2003 |
25 |
11 |
p. 2903-2919 17 p. |
artikel |
11 |
Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer
|
Simons, W.Robert |
|
2003 |
25 |
11 |
p. 2972-2987 16 p. |
artikel |
12 |
Effects of rosiglitazone maleate when added to a sulfonylurea regimen in patients with type 2 diabetes mellitus and mild to moderate renal impairment: A post hoc analysis
|
Agrawal, Arvind |
|
2003 |
25 |
11 |
p. 2754-2764 11 p. |
artikel |
13 |
Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: A two-year, randomized, placebo-controlled study
|
Hsieh, Ming-Hsiung |
|
2003 |
25 |
11 |
p. 2797-2808 12 p. |
artikel |
14 |
Measuring satisfaction with migraine treatment: Expectations, importance, outcomes, and global ratings
|
Patrick, Donald L. |
|
2003 |
25 |
11 |
p. 2920-2935 16 p. |
artikel |
15 |
Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers
|
Martin, Paul D. |
|
2003 |
25 |
11 |
p. 2822-2835 14 p. |
artikel |
16 |
Once-daily fixed-combination irbesartan 300 mg/ hydrochlorothiazide 25 mg and circadian blood pressure profile in patients with essential hypertension
|
Coca, Antonio |
|
2003 |
25 |
11 |
p. 2849-2864 16 p. |
artikel |
17 |
Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: A longitudinal cohort study
|
Balkrishnan, Rajesh |
|
2003 |
25 |
11 |
p. 2958-2971 14 p. |
artikel |
18 |
Public-private partnerships at the national institutes of health: From discovery to commercialization
|
Lyles, Alan |
|
2003 |
25 |
11 |
p. 2900-2902 3 p. |
artikel |
19 |
Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: Results of a European multicenter, open-label study of patient preference
|
Ströberg, Peter |
|
2003 |
25 |
11 |
p. 2724-2737 14 p. |
artikel |
20 |
The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonist
|
Davis, Kelli L. |
|
2003 |
25 |
11 |
p. 2647-2668 22 p. |
artikel |
21 |
The effects of intramuscular interferon beta-Ia in patients at high risk for development of multiple sclerosis: A post hoc analysis of data from CHAMPS
|
O'Connor, Paul |
|
2003 |
25 |
11 |
p. 2865-2874 10 p. |
artikel |
22 |
Tolerability of short-term, high-dose formoterol in healthy volunteers and patients with asthma
|
Ostrom, Nancy K. |
|
2003 |
25 |
11 |
p. 2635-2646 12 p. |
artikel |
23 |
(Unlearned) lessons from John Graunt and Kenneth Rothman: A “CLASSic” example
|
Arellano, Felix M. |
|
2003 |
25 |
11 |
p. 2891-2896 6 p. |
artikel |
24 |
Zoledronic acid: A new parenteral bisphosphonate
|
Li, Edward C. |
|
2003 |
25 |
11 |
p. 2669-2708 40 p. |
artikel |